A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control.
[en] Interruption of a continuous subcutaneous insulin infusion, most often due to technical problems occurring during the night, is a not uncommon event whose metabolic consequences have received relatively little attention until now. We have therefore investigated the changes in blood glucose, plasma non-esterified fatty acids, 3-hydroxybutyrate, glucagon and free insulin in eight C-peptide negative Type 1 diabetic patients whose pumps were deliberately stopped between 23.00 h and 05.00 h. A control test with the pump functioning normally was carried out in each patient and the studies were randomized. Considering the values at 23.00 h as reference, interruption of the insulin infusion resulted in (1) a rapid decrease in plasma free insulin significant after 1 h and reaching a nadir of 6 +/- 2 mU/l after 6 h; (2) a rise in blood glucose which was significant at hour 3 and reached 17.4 +/- 1.9 mmol/l at hour 6; (3) a moderate increase in plasma nonesterified fatty acids which remained in the range of 700-800 mumol/l; (4) an early and linear rise in plasma 3-hydroxybutyrate, significant after 1 h and averaging 1290 +/- 140 mumol/l after 6 h; (5) a late increase (hour 5) in plasma glucagon. The second aim of our study was to provide for the patient a precise scheme of insulin supplements administered via the pump and based on blood glucose monitoring (Dextrostix - Glucometer) and semi-quantitative evaluation of ketonuria (Acetest). Resetting the pump at its basal rate at 05.00 h and giving insulin supplements (2-8 U) at 06.45 h (with the usual breakfast dose) and again at 10.00 h have proved efficacious in restoring satisfactory metabolic control by noon the day after starting the experiment. These results form practical recommendations to patients undergoing this type of accident.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Krzentowski, G.
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Castillo, M.
Luyckx, A. S.
Lefebvre, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Language :
English
Title :
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Pirart J. (1977) Diabète et complications dégénératives. Présentation d'une étude prospective portant sur 4400 cas observés entre 1947 et 1973. Diabète Metab 3:97-107.
Pickup J.C., Keen H., Parsons J.A., Alberti K.G.M.M. (1978) Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J 1:204-207.
Pickup J.C., Keen H. (1979) Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics. Lancet 1:1255-1258.
Tamborlane W., Sherwin R.S., Genel M., Felig P. (1979) Restoration of normal lipid and amino acid metabolism in diabetic patients treated with a portable insulin-infusion pump. Lancet 1:1258-1261.
Keller U., Schade D.S. (1981) Current status of portable insulin infusion devices. Diabetologia 21:425-426.
Pickup J.C., Viberti G.C., Bilous R.W., Keen H., Alberti K.G.M.M., Home P.D., Binder C. (1982) Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia 22:175-179.
Champion M.C., Shepherd G.A.A., Rodger N.W., Dupre J. (1980) Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes 29:206-212.
Dole V.P., Meinertz H. (1960) Microdetermination of long chain fatty acids in plasma and tissues. J Biol Chem 235:2595-2599.
Nakagawa S., Nakayama H., Sossaki T., Yoshimo K., Yu Y., Shimozaki K., Aoki S., Mashimo K. (1973) Simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes 22:590-600.
Sulon J., Demey-Ponsart E., Bauduin P., Sodoyez J.C. (1978) Radioimmunoassay of corticosterone, cortisol and cortisone: their application to human cord and maternal plasma. J Steroid Biochem 9:671-676.
Heding L.G. (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11:541-548.
Kemmler W., Gerbitz K.D., Hauner H., Piwernetz K., Hepp K.D., Renner R. (1980) The insulin levels necessary for good metabolic control with intravenous insulin therapy. New approaches to insulin therapy , K., Irsigler, K.N., Kunz, D.R., Owens, H., Regal, MTP Press, Lancaster; 171-179.
Kraegen E.W. (1980) The necessity and feasibility of normalizing plasma insulin levels in diabetics using insulin delivery systems. New approaches to insulin therapy , K., Irsigler, K.N., Kunz, D.R., Owens, H., Regal, MTP Press, Lancaster; 249-256.
Gerich J.E., Lorenzi M., Bier D.M., Schneider V., Tsalikian E., Karam J.H., Forsham P.H. (1975) Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. N Engl J Med 292:985-989.
McGarry J.D., Foster D.W. (1980) Regulation of hepatic fatty acid oxidation and ketone body production. Ann Rev Biochem 49:395-420.
Keen H., Pickup J.C., Viberti G.C., Bilous R., Willia G. (1981) Aspects of continuous subcutaneous insulin infusion in diabetes. Diabetes Care 4:54-57.
Fishman V., Fishman M. (1982) Practical problems with insulin pumps. New Engl J Med 306:1369.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.